1.52
0.02 (1.33%)
| Previous Close | 1.50 |
| Open | 1.46 |
| Volume | 1,621,289 |
| Avg. Volume (3M) | 4,255,916 |
| Market Cap | 192,035,456 |
| Price / Sales | 1.93 |
| Price / Book | 39.99 |
| 52 Weeks Range | |
| Earnings Date | 26 Mar 2026 |
| Profit Margin | -38.58% |
| Operating Margin (TTM) | -39.35% |
| Diluted EPS (TTM) | -0.400 |
| Quarterly Earnings Growth (YOY) | 378.90% |
| Total Debt/Equity (MRQ) | 48.89% |
| Current Ratio (MRQ) | 0.830 |
| Operating Cash Flow (TTM) | 1.78 M |
| Levered Free Cash Flow (TTM) | 5.68 M |
| Return on Assets (TTM) | -10.26% |
| Return on Equity (TTM) | -37.82% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Software - Application (US) | Bearish | Bearish |
| Software - Application (Global) | Bearish | Bearish | |
| Stock | ALT5 Sigma Corporation | - | - |
AIStockmoo Score
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -1.00 |
|
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment. |
|
| Sector | Technology |
| Industry | Software - Application |
| Investment Style | Small Value |
| % Held by Insiders | 13.14% |
| % Held by Institutions | 7.89% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |